Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
   

 

TTD Drug ID: DNC003635

Drug Information
Name3,6-Di-pyridin-4-yl-pyrazolo[1,5-a]pyrimidine
IndicationNot AvailableExperimental    
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
InChI1S/C16H11N5/c1-5-17-6-2-12(1)14-9-19-16-15(10-20-21(16)11-14)13-3
-7-18-8-4-13/h1-11H
InChIKeyZLISHOMLHVNDJG-UHFFFAOYSA-N
Canonical SMILESC1=CN=CC=C1C2=CN3C(=C(C=N3)C4=CC=NC=C4)N=C2    
TargetVascular endothelial growth factor receptor 1Inhibitor[1]
Vascular endothelial growth factor receptor 2Inhibitor[2]
Vascular endothelial growth factor receptor 3Inhibitor[1]
Ref 1Bioorg Med Chem Lett. 2002 Oct 7;12(19):2767-70.Synthesis and initial SAR studies of 3,6-disubstituted pyrazolo[1,5-a]pyrimidines: a new class of KDR kinase inhibitors. To Reference
Ref 2Bioorg Med Chem Lett. 2002 Dec 16;12(24):3537-41.Optimization of a pyrazolo[1,5-a]pyrimidine class of KDR kinase inhibitors: improvements in physical properties enhance cellular activity and pharmacokinetics. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

   
 
 
Computer-aided Drug Design
about BIDD |  databases |  software |  teaching |  research |  links

 

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543